Browsing Investigación Aplicada by Author "Basquiera, Ana."
Now showing items 1-4 of 4
-
Allogeneic hematopoietic stem cell transplantation in pediatric myelodysplastic syndromes: a multicenter experience from Argentina.
Basquiera, Ana.; Pizzi, Silvia.; González, Agustin.; Longo, Pablo.; Goldman, Wanda.; Prates, María.; Formisano, Sandra.; et al. (Wiley, 2015-01-01)BACKGROUND: Allogeneic hematopoietic stem cell transplantation (AHSCT) represents the only curative treatment for the majority of pediatric patients with Myelodysplastic Syndrome (MDS). We aimed to evaluate overall survival ... -
Haploidentical transplant in adult patients with acute lymphoblastic leukemia in Argentina: a comparison with matched related and unrelated donors.
Berro, Mariano.; Kusminsky, Gustavo.; Basquiera, Ana.; Et al. (Springer Nature, 2020-02)Abstract We aimed at analyzing the outcome of allogeneic stem cell transplant (ASCT) in adult patients with acute lymphoblastic leukemia (ALL), comparing Haploidentical (Haplo) with HLA-matched (sibling and unrelated) ... -
Hematopoietic Cell Transplantation-Specific Comorbidity Index Predicts Morbidity and Mortality in Autologous Stem Cell Transplantation.
Berro, Mariano.; Arbeldibe, Jorge.; Rivas, María.; Basquiera, Ana.; Ferini, Gonzalo.; Vitriú, Adriana.; Foncuberta, Cecilia.; et al. (Elsevier, 2017-10-01)The hematopoietic cell transplantation-specific comorbidity index (HCT-CI) score is a useful tool to assess the risk for nonrelapse mortality (NRM) after allogeneic hematopoietic stem cell transplantation. Although the ... -
The Latin American experience of allografting patients with severe aplastic anaemia: real-world data on the impact of stem cell source and ATG administration in HLA-identical sibling transplants
Gomez-Almaguer, D.; Vázquez-Mellado, A.; Navarro Cabrera, J.R.; Abello-Polo, V.; Milovic, V.; Garcia, J.; Basquiera, Ana.; et al. (Springer Nature [academic journals on nature.com], 2017-01-01)We studied 298 patients with severe aplastic anaemia (SAA) allografted in four Latin American countries. The source of cells was bone marrow (BM) in 94 patients and PBSCs in 204 patients. Engraftment failed in 8.1% of ...